nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—ABCB1—Mitomycin—stomach cancer	0.118	0.307	CbGbCtD
Citalopram—CYP2B6—Irinotecan—stomach cancer	0.0588	0.154	CbGbCtD
Citalopram—CYP1A2—Fluorouracil—stomach cancer	0.0331	0.0864	CbGbCtD
Citalopram—CYP2B6—Doxorubicin—stomach cancer	0.0321	0.0839	CbGbCtD
Citalopram—ABCB1—Irinotecan—stomach cancer	0.0302	0.0787	CbGbCtD
Citalopram—ABCB1—Docetaxel—stomach cancer	0.0221	0.0577	CbGbCtD
Citalopram—CYP3A4—Irinotecan—stomach cancer	0.0181	0.0472	CbGbCtD
Citalopram—ABCB1—Doxorubicin—stomach cancer	0.0165	0.043	CbGbCtD
Citalopram—ABCB1—Methotrexate—stomach cancer	0.016	0.0417	CbGbCtD
Citalopram—CYP2D6—Doxorubicin—stomach cancer	0.0155	0.0405	CbGbCtD
Citalopram—CYP3A4—Docetaxel—stomach cancer	0.0132	0.0346	CbGbCtD
Citalopram—CYP3A4—Doxorubicin—stomach cancer	0.00988	0.0258	CbGbCtD
Citalopram—SLC6A3—hematopoietic system—stomach cancer	0.001	0.044	CbGeAlD
Citalopram—SLC6A4—hematopoietic system—stomach cancer	0.00092	0.0404	CbGeAlD
Citalopram—CYP2C19—hematopoietic system—stomach cancer	0.000762	0.0334	CbGeAlD
Citalopram—ADRA1A—hematopoietic system—stomach cancer	0.000753	0.033	CbGeAlD
Citalopram—ADRA1A—epithelium—stomach cancer	0.000688	0.0302	CbGeAlD
Citalopram—SLC6A4—digestive system—stomach cancer	0.00064	0.0281	CbGeAlD
Citalopram—CYP1A2—hematopoietic system—stomach cancer	0.000623	0.0273	CbGeAlD
Citalopram—ABCB1—blood vessel—stomach cancer	0.000599	0.0263	CbGeAlD
Citalopram—CYP2B6—hematopoietic system—stomach cancer	0.000597	0.0262	CbGeAlD
Citalopram—HRH1—hematopoietic system—stomach cancer	0.000583	0.0256	CbGeAlD
Citalopram—CYP2E1—hematopoietic system—stomach cancer	0.00056	0.0246	CbGeAlD
Citalopram—HRH1—epithelium—stomach cancer	0.000533	0.0234	CbGeAlD
Citalopram—CYP2C19—digestive system—stomach cancer	0.00053	0.0233	CbGeAlD
Citalopram—ADRA1A—lymphoid tissue—stomach cancer	0.00053	0.0233	CbGeAlD
Citalopram—SLC6A4—endocrine gland—stomach cancer	0.000529	0.0232	CbGeAlD
Citalopram—CHRM1—endocrine gland—stomach cancer	0.000527	0.0231	CbGeAlD
Citalopram—HRH1—smooth muscle tissue—stomach cancer	0.000513	0.0225	CbGeAlD
Citalopram—SLC6A2—endocrine gland—stomach cancer	0.000465	0.0204	CbGeAlD
Citalopram—CYP3A4—hematopoietic system—stomach cancer	0.000451	0.0198	CbGeAlD
Citalopram—CYP2D6—hematopoietic system—stomach cancer	0.000444	0.0195	CbGeAlD
Citalopram—CYP2C19—endocrine gland—stomach cancer	0.000438	0.0192	CbGeAlD
Citalopram—CYP1A2—digestive system—stomach cancer	0.000433	0.019	CbGeAlD
Citalopram—ADRA1A—endocrine gland—stomach cancer	0.000433	0.019	CbGeAlD
Citalopram—CYP2B6—lymphoid tissue—stomach cancer	0.00042	0.0184	CbGeAlD
Citalopram—CYP2B6—digestive system—stomach cancer	0.000415	0.0182	CbGeAlD
Citalopram—HRH1—digestive system—stomach cancer	0.000405	0.0178	CbGeAlD
Citalopram—CYP2C19—liver—stomach cancer	0.000395	0.0173	CbGeAlD
Citalopram—CYP2E1—lymphoid tissue—stomach cancer	0.000394	0.0173	CbGeAlD
Citalopram—ADRA1A—liver—stomach cancer	0.00039	0.0171	CbGeAlD
Citalopram—CYP2E1—digestive system—stomach cancer	0.00039	0.0171	CbGeAlD
Citalopram—CYP1A2—endocrine gland—stomach cancer	0.000358	0.0157	CbGeAlD
Citalopram—CYP2B6—endocrine gland—stomach cancer	0.000343	0.015	CbGeAlD
Citalopram—HRH1—endocrine gland—stomach cancer	0.000335	0.0147	CbGeAlD
Citalopram—CYP1A2—liver—stomach cancer	0.000323	0.0142	CbGeAlD
Citalopram—CYP2E1—endocrine gland—stomach cancer	0.000322	0.0141	CbGeAlD
Citalopram—SLC6A2—lymph node—stomach cancer	0.000322	0.0141	CbGeAlD
Citalopram—ABCB1—hematopoietic system—stomach cancer	0.000319	0.014	CbGeAlD
Citalopram—CYP3A4—digestive system—stomach cancer	0.000313	0.0137	CbGeAlD
Citalopram—CYP2B6—liver—stomach cancer	0.000309	0.0136	CbGeAlD
Citalopram—CYP2D6—digestive system—stomach cancer	0.000308	0.0135	CbGeAlD
Citalopram—ABCB1—epithelium—stomach cancer	0.000292	0.0128	CbGeAlD
Citalopram—CYP2E1—liver—stomach cancer	0.00029	0.0127	CbGeAlD
Citalopram—ABCB1—pancreas—stomach cancer	0.00026	0.0114	CbGeAlD
Citalopram—CYP3A4—endocrine gland—stomach cancer	0.000259	0.0114	CbGeAlD
Citalopram—CYP2D6—endocrine gland—stomach cancer	0.000255	0.0112	CbGeAlD
Citalopram—CYP3A4—liver—stomach cancer	0.000234	0.0102	CbGeAlD
Citalopram—HRH1—lymph node—stomach cancer	0.000232	0.0102	CbGeAlD
Citalopram—CYP2D6—liver—stomach cancer	0.00023	0.0101	CbGeAlD
Citalopram—ABCB1—lymphoid tissue—stomach cancer	0.000225	0.00985	CbGeAlD
Citalopram—ABCB1—digestive system—stomach cancer	0.000222	0.00973	CbGeAlD
Citalopram—ABCB1—bone marrow—stomach cancer	0.000205	0.00897	CbGeAlD
Citalopram—ABCB1—endocrine gland—stomach cancer	0.000183	0.00804	CbGeAlD
Citalopram—ABCB1—liver—stomach cancer	0.000165	0.00725	CbGeAlD
Citalopram—ABCB1—lymph node—stomach cancer	0.000127	0.00556	CbGeAlD
Citalopram—Paraesthesia—Capecitabine—stomach cancer	0.000102	0.000221	CcSEcCtD
Citalopram—Decreased appetite—Docetaxel—stomach cancer	0.000102	0.000221	CcSEcCtD
Citalopram—Headache—Fluorouracil—stomach cancer	0.000101	0.00022	CcSEcCtD
Citalopram—Urinary tract disorder—Doxorubicin—stomach cancer	0.000101	0.00022	CcSEcCtD
Citalopram—Oedema peripheral—Doxorubicin—stomach cancer	0.000101	0.00022	CcSEcCtD
Citalopram—Dysgeusia—Methotrexate—stomach cancer	0.000101	0.00022	CcSEcCtD
Citalopram—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000101	0.000219	CcSEcCtD
Citalopram—Connective tissue disorder—Doxorubicin—stomach cancer	0.000101	0.000219	CcSEcCtD
Citalopram—Dyspnoea—Capecitabine—stomach cancer	0.000101	0.000219	CcSEcCtD
Citalopram—Fatigue—Docetaxel—stomach cancer	0.000101	0.000219	CcSEcCtD
Citalopram—Angiopathy—Epirubicin—stomach cancer	0.000101	0.000219	CcSEcCtD
Citalopram—Urethral disorder—Doxorubicin—stomach cancer	0.000101	0.000219	CcSEcCtD
Citalopram—Nausea—Irinotecan—stomach cancer	0.0001	0.000218	CcSEcCtD
Citalopram—Immune system disorder—Epirubicin—stomach cancer	0.0001	0.000218	CcSEcCtD
Citalopram—Mediastinal disorder—Epirubicin—stomach cancer	0.0001	0.000217	CcSEcCtD
Citalopram—Constipation—Docetaxel—stomach cancer	0.0001	0.000217	CcSEcCtD
Citalopram—Pain—Docetaxel—stomach cancer	0.0001	0.000217	CcSEcCtD
Citalopram—Back pain—Methotrexate—stomach cancer	9.99e-05	0.000217	CcSEcCtD
Citalopram—Dyspepsia—Capecitabine—stomach cancer	9.96e-05	0.000216	CcSEcCtD
Citalopram—Chills—Epirubicin—stomach cancer	9.96e-05	0.000216	CcSEcCtD
Citalopram—Arrhythmia—Epirubicin—stomach cancer	9.91e-05	0.000215	CcSEcCtD
Citalopram—Visual impairment—Doxorubicin—stomach cancer	9.9e-05	0.000215	CcSEcCtD
Citalopram—Decreased appetite—Capecitabine—stomach cancer	9.84e-05	0.000214	CcSEcCtD
Citalopram—Alopecia—Epirubicin—stomach cancer	9.81e-05	0.000213	CcSEcCtD
Citalopram—Gastrointestinal disorder—Capecitabine—stomach cancer	9.77e-05	0.000212	CcSEcCtD
Citalopram—Fatigue—Capecitabine—stomach cancer	9.76e-05	0.000212	CcSEcCtD
Citalopram—Vision blurred—Methotrexate—stomach cancer	9.73e-05	0.000211	CcSEcCtD
Citalopram—Mental disorder—Epirubicin—stomach cancer	9.72e-05	0.000211	CcSEcCtD
Citalopram—Erythema multiforme—Doxorubicin—stomach cancer	9.71e-05	0.000211	CcSEcCtD
Citalopram—Pain—Capecitabine—stomach cancer	9.68e-05	0.00021	CcSEcCtD
Citalopram—Constipation—Capecitabine—stomach cancer	9.68e-05	0.00021	CcSEcCtD
Citalopram—Erythema—Epirubicin—stomach cancer	9.66e-05	0.00021	CcSEcCtD
Citalopram—Malnutrition—Epirubicin—stomach cancer	9.66e-05	0.00021	CcSEcCtD
Citalopram—Feeling abnormal—Docetaxel—stomach cancer	9.63e-05	0.000209	CcSEcCtD
Citalopram—Nausea—Fluorouracil—stomach cancer	9.62e-05	0.000209	CcSEcCtD
Citalopram—Eye disorder—Doxorubicin—stomach cancer	9.6e-05	0.000208	CcSEcCtD
Citalopram—Ill-defined disorder—Methotrexate—stomach cancer	9.58e-05	0.000208	CcSEcCtD
Citalopram—Tinnitus—Doxorubicin—stomach cancer	9.57e-05	0.000208	CcSEcCtD
Citalopram—Gastrointestinal pain—Docetaxel—stomach cancer	9.56e-05	0.000208	CcSEcCtD
Citalopram—Anaemia—Methotrexate—stomach cancer	9.54e-05	0.000207	CcSEcCtD
Citalopram—Flushing—Doxorubicin—stomach cancer	9.53e-05	0.000207	CcSEcCtD
Citalopram—Cardiac disorder—Doxorubicin—stomach cancer	9.53e-05	0.000207	CcSEcCtD
Citalopram—Flatulence—Epirubicin—stomach cancer	9.52e-05	0.000207	CcSEcCtD
Citalopram—Tension—Epirubicin—stomach cancer	9.48e-05	0.000206	CcSEcCtD
Citalopram—Dysgeusia—Epirubicin—stomach cancer	9.46e-05	0.000205	CcSEcCtD
Citalopram—Nervousness—Epirubicin—stomach cancer	9.38e-05	0.000204	CcSEcCtD
Citalopram—Back pain—Epirubicin—stomach cancer	9.34e-05	0.000203	CcSEcCtD
Citalopram—Feeling abnormal—Capecitabine—stomach cancer	9.33e-05	0.000203	CcSEcCtD
Citalopram—Angiopathy—Doxorubicin—stomach cancer	9.32e-05	0.000202	CcSEcCtD
Citalopram—Malaise—Methotrexate—stomach cancer	9.31e-05	0.000202	CcSEcCtD
Citalopram—Muscle spasms—Epirubicin—stomach cancer	9.29e-05	0.000202	CcSEcCtD
Citalopram—Immune system disorder—Doxorubicin—stomach cancer	9.27e-05	0.000201	CcSEcCtD
Citalopram—Vertigo—Methotrexate—stomach cancer	9.27e-05	0.000201	CcSEcCtD
Citalopram—Gastrointestinal pain—Capecitabine—stomach cancer	9.25e-05	0.000201	CcSEcCtD
Citalopram—Mediastinal disorder—Doxorubicin—stomach cancer	9.25e-05	0.000201	CcSEcCtD
Citalopram—Abdominal pain—Docetaxel—stomach cancer	9.24e-05	0.000201	CcSEcCtD
Citalopram—Body temperature increased—Docetaxel—stomach cancer	9.24e-05	0.000201	CcSEcCtD
Citalopram—Leukopenia—Methotrexate—stomach cancer	9.24e-05	0.000201	CcSEcCtD
Citalopram—Chills—Doxorubicin—stomach cancer	9.21e-05	0.0002	CcSEcCtD
Citalopram—Arrhythmia—Doxorubicin—stomach cancer	9.17e-05	0.000199	CcSEcCtD
Citalopram—Vision blurred—Epirubicin—stomach cancer	9.1e-05	0.000198	CcSEcCtD
Citalopram—Alopecia—Doxorubicin—stomach cancer	9.07e-05	0.000197	CcSEcCtD
Citalopram—Cough—Methotrexate—stomach cancer	9.01e-05	0.000196	CcSEcCtD
Citalopram—Mental disorder—Doxorubicin—stomach cancer	9e-05	0.000195	CcSEcCtD
Citalopram—Urticaria—Capecitabine—stomach cancer	8.99e-05	0.000195	CcSEcCtD
Citalopram—Ill-defined disorder—Epirubicin—stomach cancer	8.96e-05	0.000195	CcSEcCtD
Citalopram—Abdominal pain—Capecitabine—stomach cancer	8.95e-05	0.000194	CcSEcCtD
Citalopram—Body temperature increased—Capecitabine—stomach cancer	8.95e-05	0.000194	CcSEcCtD
Citalopram—Convulsion—Methotrexate—stomach cancer	8.94e-05	0.000194	CcSEcCtD
Citalopram—Erythema—Doxorubicin—stomach cancer	8.94e-05	0.000194	CcSEcCtD
Citalopram—Malnutrition—Doxorubicin—stomach cancer	8.94e-05	0.000194	CcSEcCtD
Citalopram—Anaemia—Epirubicin—stomach cancer	8.93e-05	0.000194	CcSEcCtD
Citalopram—Agitation—Epirubicin—stomach cancer	8.88e-05	0.000193	CcSEcCtD
Citalopram—Flatulence—Doxorubicin—stomach cancer	8.81e-05	0.000191	CcSEcCtD
Citalopram—Myalgia—Methotrexate—stomach cancer	8.79e-05	0.000191	CcSEcCtD
Citalopram—Chest pain—Methotrexate—stomach cancer	8.79e-05	0.000191	CcSEcCtD
Citalopram—Arthralgia—Methotrexate—stomach cancer	8.79e-05	0.000191	CcSEcCtD
Citalopram—Tension—Doxorubicin—stomach cancer	8.77e-05	0.000191	CcSEcCtD
Citalopram—Dysgeusia—Doxorubicin—stomach cancer	8.75e-05	0.00019	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	8.73e-05	0.00019	CcSEcCtD
Citalopram—Malaise—Epirubicin—stomach cancer	8.71e-05	0.000189	CcSEcCtD
Citalopram—Discomfort—Methotrexate—stomach cancer	8.68e-05	0.000189	CcSEcCtD
Citalopram—Nervousness—Doxorubicin—stomach cancer	8.68e-05	0.000189	CcSEcCtD
Citalopram—Vertigo—Epirubicin—stomach cancer	8.68e-05	0.000189	CcSEcCtD
Citalopram—Syncope—Epirubicin—stomach cancer	8.66e-05	0.000188	CcSEcCtD
Citalopram—Leukopenia—Epirubicin—stomach cancer	8.65e-05	0.000188	CcSEcCtD
Citalopram—Back pain—Doxorubicin—stomach cancer	8.65e-05	0.000188	CcSEcCtD
Citalopram—Hypersensitivity—Docetaxel—stomach cancer	8.61e-05	0.000187	CcSEcCtD
Citalopram—Muscle spasms—Doxorubicin—stomach cancer	8.59e-05	0.000187	CcSEcCtD
Citalopram—Palpitations—Epirubicin—stomach cancer	8.54e-05	0.000185	CcSEcCtD
Citalopram—Confusional state—Methotrexate—stomach cancer	8.49e-05	0.000185	CcSEcCtD
Citalopram—Loss of consciousness—Epirubicin—stomach cancer	8.49e-05	0.000184	CcSEcCtD
Citalopram—Cough—Epirubicin—stomach cancer	8.43e-05	0.000183	CcSEcCtD
Citalopram—Anaphylactic shock—Methotrexate—stomach cancer	8.42e-05	0.000183	CcSEcCtD
Citalopram—Vision blurred—Doxorubicin—stomach cancer	8.42e-05	0.000183	CcSEcCtD
Citalopram—Asthenia—Docetaxel—stomach cancer	8.39e-05	0.000182	CcSEcCtD
Citalopram—Convulsion—Epirubicin—stomach cancer	8.37e-05	0.000182	CcSEcCtD
Citalopram—Infection—Methotrexate—stomach cancer	8.37e-05	0.000182	CcSEcCtD
Citalopram—Hypertension—Epirubicin—stomach cancer	8.34e-05	0.000181	CcSEcCtD
Citalopram—Hypersensitivity—Capecitabine—stomach cancer	8.34e-05	0.000181	CcSEcCtD
Citalopram—Ill-defined disorder—Doxorubicin—stomach cancer	8.29e-05	0.00018	CcSEcCtD
Citalopram—Pruritus—Docetaxel—stomach cancer	8.27e-05	0.00018	CcSEcCtD
Citalopram—Nervous system disorder—Methotrexate—stomach cancer	8.26e-05	0.000179	CcSEcCtD
Citalopram—Anaemia—Doxorubicin—stomach cancer	8.26e-05	0.000179	CcSEcCtD
Citalopram—Thrombocytopenia—Methotrexate—stomach cancer	8.25e-05	0.000179	CcSEcCtD
Citalopram—Chest pain—Epirubicin—stomach cancer	8.22e-05	0.000179	CcSEcCtD
Citalopram—Myalgia—Epirubicin—stomach cancer	8.22e-05	0.000179	CcSEcCtD
Citalopram—Arthralgia—Epirubicin—stomach cancer	8.22e-05	0.000179	CcSEcCtD
Citalopram—Agitation—Doxorubicin—stomach cancer	8.21e-05	0.000178	CcSEcCtD
Citalopram—Anxiety—Epirubicin—stomach cancer	8.2e-05	0.000178	CcSEcCtD
Citalopram—Skin disorder—Methotrexate—stomach cancer	8.18e-05	0.000178	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	8.17e-05	0.000177	CcSEcCtD
Citalopram—Hyperhidrosis—Methotrexate—stomach cancer	8.14e-05	0.000177	CcSEcCtD
Citalopram—Discomfort—Epirubicin—stomach cancer	8.13e-05	0.000177	CcSEcCtD
Citalopram—Asthenia—Capecitabine—stomach cancer	8.12e-05	0.000176	CcSEcCtD
Citalopram—Malaise—Doxorubicin—stomach cancer	8.06e-05	0.000175	CcSEcCtD
Citalopram—Dry mouth—Epirubicin—stomach cancer	8.04e-05	0.000175	CcSEcCtD
Citalopram—Vertigo—Doxorubicin—stomach cancer	8.03e-05	0.000174	CcSEcCtD
Citalopram—Anorexia—Methotrexate—stomach cancer	8.03e-05	0.000174	CcSEcCtD
Citalopram—Syncope—Doxorubicin—stomach cancer	8.02e-05	0.000174	CcSEcCtD
Citalopram—Pruritus—Capecitabine—stomach cancer	8.01e-05	0.000174	CcSEcCtD
Citalopram—Leukopenia—Doxorubicin—stomach cancer	8e-05	0.000174	CcSEcCtD
Citalopram—Diarrhoea—Docetaxel—stomach cancer	8e-05	0.000174	CcSEcCtD
Citalopram—Confusional state—Epirubicin—stomach cancer	7.95e-05	0.000173	CcSEcCtD
Citalopram—Palpitations—Doxorubicin—stomach cancer	7.9e-05	0.000172	CcSEcCtD
Citalopram—Oedema—Epirubicin—stomach cancer	7.88e-05	0.000171	CcSEcCtD
Citalopram—Anaphylactic shock—Epirubicin—stomach cancer	7.88e-05	0.000171	CcSEcCtD
Citalopram—Hypotension—Methotrexate—stomach cancer	7.87e-05	0.000171	CcSEcCtD
Citalopram—Loss of consciousness—Doxorubicin—stomach cancer	7.86e-05	0.000171	CcSEcCtD
Citalopram—Infection—Epirubicin—stomach cancer	7.83e-05	0.00017	CcSEcCtD
Citalopram—Cough—Doxorubicin—stomach cancer	7.8e-05	0.000169	CcSEcCtD
Citalopram—Shock—Epirubicin—stomach cancer	7.76e-05	0.000168	CcSEcCtD
Citalopram—Convulsion—Doxorubicin—stomach cancer	7.74e-05	0.000168	CcSEcCtD
Citalopram—Diarrhoea—Capecitabine—stomach cancer	7.74e-05	0.000168	CcSEcCtD
Citalopram—Nervous system disorder—Epirubicin—stomach cancer	7.73e-05	0.000168	CcSEcCtD
Citalopram—Dizziness—Docetaxel—stomach cancer	7.73e-05	0.000168	CcSEcCtD
Citalopram—Thrombocytopenia—Epirubicin—stomach cancer	7.72e-05	0.000168	CcSEcCtD
Citalopram—Hypertension—Doxorubicin—stomach cancer	7.72e-05	0.000168	CcSEcCtD
Citalopram—Tachycardia—Epirubicin—stomach cancer	7.69e-05	0.000167	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Methotrexate—stomach cancer	7.68e-05	0.000167	CcSEcCtD
Citalopram—Skin disorder—Epirubicin—stomach cancer	7.66e-05	0.000166	CcSEcCtD
Citalopram—Hyperhidrosis—Epirubicin—stomach cancer	7.62e-05	0.000166	CcSEcCtD
Citalopram—Insomnia—Methotrexate—stomach cancer	7.62e-05	0.000166	CcSEcCtD
Citalopram—Myalgia—Doxorubicin—stomach cancer	7.61e-05	0.000165	CcSEcCtD
Citalopram—Chest pain—Doxorubicin—stomach cancer	7.61e-05	0.000165	CcSEcCtD
Citalopram—Arthralgia—Doxorubicin—stomach cancer	7.61e-05	0.000165	CcSEcCtD
Citalopram—Anxiety—Doxorubicin—stomach cancer	7.58e-05	0.000165	CcSEcCtD
Citalopram—Paraesthesia—Methotrexate—stomach cancer	7.57e-05	0.000164	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	7.56e-05	0.000164	CcSEcCtD
Citalopram—Discomfort—Doxorubicin—stomach cancer	7.52e-05	0.000163	CcSEcCtD
Citalopram—Anorexia—Epirubicin—stomach cancer	7.52e-05	0.000163	CcSEcCtD
Citalopram—Dyspnoea—Methotrexate—stomach cancer	7.51e-05	0.000163	CcSEcCtD
Citalopram—Somnolence—Methotrexate—stomach cancer	7.49e-05	0.000163	CcSEcCtD
Citalopram—Dizziness—Capecitabine—stomach cancer	7.48e-05	0.000163	CcSEcCtD
Citalopram—Dry mouth—Doxorubicin—stomach cancer	7.44e-05	0.000162	CcSEcCtD
Citalopram—Vomiting—Docetaxel—stomach cancer	7.43e-05	0.000161	CcSEcCtD
Citalopram—Dyspepsia—Methotrexate—stomach cancer	7.42e-05	0.000161	CcSEcCtD
Citalopram—Rash—Docetaxel—stomach cancer	7.37e-05	0.00016	CcSEcCtD
Citalopram—Hypotension—Epirubicin—stomach cancer	7.37e-05	0.00016	CcSEcCtD
Citalopram—Dermatitis—Docetaxel—stomach cancer	7.36e-05	0.00016	CcSEcCtD
Citalopram—Confusional state—Doxorubicin—stomach cancer	7.36e-05	0.00016	CcSEcCtD
Citalopram—Decreased appetite—Methotrexate—stomach cancer	7.32e-05	0.000159	CcSEcCtD
Citalopram—Headache—Docetaxel—stomach cancer	7.32e-05	0.000159	CcSEcCtD
Citalopram—Oedema—Doxorubicin—stomach cancer	7.3e-05	0.000158	CcSEcCtD
Citalopram—Anaphylactic shock—Doxorubicin—stomach cancer	7.3e-05	0.000158	CcSEcCtD
Citalopram—Gastrointestinal disorder—Methotrexate—stomach cancer	7.27e-05	0.000158	CcSEcCtD
Citalopram—Fatigue—Methotrexate—stomach cancer	7.26e-05	0.000158	CcSEcCtD
Citalopram—Infection—Doxorubicin—stomach cancer	7.25e-05	0.000157	CcSEcCtD
Citalopram—Pain—Methotrexate—stomach cancer	7.2e-05	0.000156	CcSEcCtD
Citalopram—Vomiting—Capecitabine—stomach cancer	7.2e-05	0.000156	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Epirubicin—stomach cancer	7.18e-05	0.000156	CcSEcCtD
Citalopram—Shock—Doxorubicin—stomach cancer	7.18e-05	0.000156	CcSEcCtD
Citalopram—Nervous system disorder—Doxorubicin—stomach cancer	7.15e-05	0.000155	CcSEcCtD
Citalopram—Thrombocytopenia—Doxorubicin—stomach cancer	7.14e-05	0.000155	CcSEcCtD
Citalopram—Rash—Capecitabine—stomach cancer	7.14e-05	0.000155	CcSEcCtD
Citalopram—Insomnia—Epirubicin—stomach cancer	7.13e-05	0.000155	CcSEcCtD
Citalopram—Dermatitis—Capecitabine—stomach cancer	7.13e-05	0.000155	CcSEcCtD
Citalopram—Tachycardia—Doxorubicin—stomach cancer	7.12e-05	0.000155	CcSEcCtD
Citalopram—Headache—Capecitabine—stomach cancer	7.09e-05	0.000154	CcSEcCtD
Citalopram—Skin disorder—Doxorubicin—stomach cancer	7.09e-05	0.000154	CcSEcCtD
Citalopram—Paraesthesia—Epirubicin—stomach cancer	7.08e-05	0.000154	CcSEcCtD
Citalopram—Hyperhidrosis—Doxorubicin—stomach cancer	7.05e-05	0.000153	CcSEcCtD
Citalopram—Dyspnoea—Epirubicin—stomach cancer	7.03e-05	0.000153	CcSEcCtD
Citalopram—Somnolence—Epirubicin—stomach cancer	7.01e-05	0.000152	CcSEcCtD
Citalopram—Anorexia—Doxorubicin—stomach cancer	6.95e-05	0.000151	CcSEcCtD
Citalopram—Nausea—Docetaxel—stomach cancer	6.94e-05	0.000151	CcSEcCtD
Citalopram—Feeling abnormal—Methotrexate—stomach cancer	6.94e-05	0.000151	CcSEcCtD
Citalopram—Dyspepsia—Epirubicin—stomach cancer	6.94e-05	0.000151	CcSEcCtD
Citalopram—Gastrointestinal pain—Methotrexate—stomach cancer	6.89e-05	0.00015	CcSEcCtD
Citalopram—Decreased appetite—Epirubicin—stomach cancer	6.85e-05	0.000149	CcSEcCtD
Citalopram—Hypotension—Doxorubicin—stomach cancer	6.82e-05	0.000148	CcSEcCtD
Citalopram—Gastrointestinal disorder—Epirubicin—stomach cancer	6.81e-05	0.000148	CcSEcCtD
Citalopram—Fatigue—Epirubicin—stomach cancer	6.8e-05	0.000148	CcSEcCtD
Citalopram—Pain—Epirubicin—stomach cancer	6.74e-05	0.000146	CcSEcCtD
Citalopram—Constipation—Epirubicin—stomach cancer	6.74e-05	0.000146	CcSEcCtD
Citalopram—Nausea—Capecitabine—stomach cancer	6.72e-05	0.000146	CcSEcCtD
Citalopram—Urticaria—Methotrexate—stomach cancer	6.69e-05	0.000145	CcSEcCtD
Citalopram—Abdominal pain—Methotrexate—stomach cancer	6.66e-05	0.000145	CcSEcCtD
Citalopram—Body temperature increased—Methotrexate—stomach cancer	6.66e-05	0.000145	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.65e-05	0.000144	CcSEcCtD
Citalopram—Insomnia—Doxorubicin—stomach cancer	6.6e-05	0.000143	CcSEcCtD
Citalopram—Paraesthesia—Doxorubicin—stomach cancer	6.55e-05	0.000142	CcSEcCtD
Citalopram—Dyspnoea—Doxorubicin—stomach cancer	6.5e-05	0.000141	CcSEcCtD
Citalopram—Feeling abnormal—Epirubicin—stomach cancer	6.5e-05	0.000141	CcSEcCtD
Citalopram—Somnolence—Doxorubicin—stomach cancer	6.49e-05	0.000141	CcSEcCtD
Citalopram—Gastrointestinal pain—Epirubicin—stomach cancer	6.45e-05	0.00014	CcSEcCtD
Citalopram—Dyspepsia—Doxorubicin—stomach cancer	6.42e-05	0.000139	CcSEcCtD
Citalopram—Decreased appetite—Doxorubicin—stomach cancer	6.34e-05	0.000138	CcSEcCtD
Citalopram—Gastrointestinal disorder—Doxorubicin—stomach cancer	6.3e-05	0.000137	CcSEcCtD
Citalopram—Fatigue—Doxorubicin—stomach cancer	6.29e-05	0.000137	CcSEcCtD
Citalopram—Urticaria—Epirubicin—stomach cancer	6.26e-05	0.000136	CcSEcCtD
Citalopram—Constipation—Doxorubicin—stomach cancer	6.24e-05	0.000136	CcSEcCtD
Citalopram—Pain—Doxorubicin—stomach cancer	6.24e-05	0.000136	CcSEcCtD
Citalopram—Body temperature increased—Epirubicin—stomach cancer	6.23e-05	0.000135	CcSEcCtD
Citalopram—Abdominal pain—Epirubicin—stomach cancer	6.23e-05	0.000135	CcSEcCtD
Citalopram—Hypersensitivity—Methotrexate—stomach cancer	6.21e-05	0.000135	CcSEcCtD
Citalopram—Asthenia—Methotrexate—stomach cancer	6.04e-05	0.000131	CcSEcCtD
Citalopram—Feeling abnormal—Doxorubicin—stomach cancer	6.01e-05	0.000131	CcSEcCtD
Citalopram—Gastrointestinal pain—Doxorubicin—stomach cancer	5.97e-05	0.00013	CcSEcCtD
Citalopram—Pruritus—Methotrexate—stomach cancer	5.96e-05	0.000129	CcSEcCtD
Citalopram—Hypersensitivity—Epirubicin—stomach cancer	5.81e-05	0.000126	CcSEcCtD
Citalopram—Urticaria—Doxorubicin—stomach cancer	5.8e-05	0.000126	CcSEcCtD
Citalopram—Abdominal pain—Doxorubicin—stomach cancer	5.77e-05	0.000125	CcSEcCtD
Citalopram—Body temperature increased—Doxorubicin—stomach cancer	5.77e-05	0.000125	CcSEcCtD
Citalopram—Diarrhoea—Methotrexate—stomach cancer	5.76e-05	0.000125	CcSEcCtD
Citalopram—Asthenia—Epirubicin—stomach cancer	5.66e-05	0.000123	CcSEcCtD
Citalopram—Pruritus—Epirubicin—stomach cancer	5.58e-05	0.000121	CcSEcCtD
Citalopram—Dizziness—Methotrexate—stomach cancer	5.57e-05	0.000121	CcSEcCtD
Citalopram—Diarrhoea—Epirubicin—stomach cancer	5.39e-05	0.000117	CcSEcCtD
Citalopram—Hypersensitivity—Doxorubicin—stomach cancer	5.37e-05	0.000117	CcSEcCtD
Citalopram—Vomiting—Methotrexate—stomach cancer	5.36e-05	0.000116	CcSEcCtD
Citalopram—Rash—Methotrexate—stomach cancer	5.31e-05	0.000115	CcSEcCtD
Citalopram—Dermatitis—Methotrexate—stomach cancer	5.31e-05	0.000115	CcSEcCtD
Citalopram—Headache—Methotrexate—stomach cancer	5.28e-05	0.000115	CcSEcCtD
Citalopram—Asthenia—Doxorubicin—stomach cancer	5.23e-05	0.000114	CcSEcCtD
Citalopram—Dizziness—Epirubicin—stomach cancer	5.21e-05	0.000113	CcSEcCtD
Citalopram—Pruritus—Doxorubicin—stomach cancer	5.16e-05	0.000112	CcSEcCtD
Citalopram—Vomiting—Epirubicin—stomach cancer	5.01e-05	0.000109	CcSEcCtD
Citalopram—Nausea—Methotrexate—stomach cancer	5e-05	0.000109	CcSEcCtD
Citalopram—Diarrhoea—Doxorubicin—stomach cancer	4.99e-05	0.000108	CcSEcCtD
Citalopram—Rash—Epirubicin—stomach cancer	4.97e-05	0.000108	CcSEcCtD
Citalopram—Dermatitis—Epirubicin—stomach cancer	4.97e-05	0.000108	CcSEcCtD
Citalopram—Headache—Epirubicin—stomach cancer	4.94e-05	0.000107	CcSEcCtD
Citalopram—Dizziness—Doxorubicin—stomach cancer	4.82e-05	0.000105	CcSEcCtD
Citalopram—Nausea—Epirubicin—stomach cancer	4.68e-05	0.000102	CcSEcCtD
Citalopram—Vomiting—Doxorubicin—stomach cancer	4.64e-05	0.000101	CcSEcCtD
Citalopram—Rash—Doxorubicin—stomach cancer	4.6e-05	9.99e-05	CcSEcCtD
Citalopram—Dermatitis—Doxorubicin—stomach cancer	4.6e-05	9.98e-05	CcSEcCtD
Citalopram—Headache—Doxorubicin—stomach cancer	4.57e-05	9.93e-05	CcSEcCtD
Citalopram—Nausea—Doxorubicin—stomach cancer	4.33e-05	9.41e-05	CcSEcCtD
Citalopram—HRH1—Signaling Pathways—FGFR2—stomach cancer	1.19e-05	8.9e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FGFR2—stomach cancer	1.19e-05	8.87e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.18e-05	8.81e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	1.18e-05	8.8e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—MTHFR—stomach cancer	1.17e-05	8.76e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALDOB—stomach cancer	1.17e-05	8.74e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	1.17e-05	8.73e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PRKCB—stomach cancer	1.16e-05	8.68e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6ST—stomach cancer	1.16e-05	8.65e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ENO1—stomach cancer	1.15e-05	8.58e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—MTHFR—stomach cancer	1.15e-05	8.58e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.13e-05	8.44e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.11e-05	8.31e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APC—stomach cancer	1.11e-05	8.31e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IRS2—stomach cancer	1.09e-05	8.15e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTP1—stomach cancer	1.09e-05	8.15e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALOX5—stomach cancer	1.09e-05	8.13e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IRS2—stomach cancer	1.09e-05	8.12e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.08e-05	8.11e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CAV1—stomach cancer	1.08e-05	8.08e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—APOA1—stomach cancer	1.08e-05	8.06e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—HMOX1—stomach cancer	1.07e-05	8.04e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IRS2—stomach cancer	1.07e-05	8e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—DPYD—stomach cancer	1.07e-05	7.99e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—MAPK3—stomach cancer	1.06e-05	7.96e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTP1—stomach cancer	1.06e-05	7.95e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CAV1—stomach cancer	1.06e-05	7.91e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CAV1—stomach cancer	1.06e-05	7.9e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—APOA1—stomach cancer	1.06e-05	7.89e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APOA1—stomach cancer	1.05e-05	7.88e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CAV1—stomach cancer	1.05e-05	7.88e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APOA1—stomach cancer	1.05e-05	7.86e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—HMOX1—stomach cancer	1.05e-05	7.84e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CAV1—stomach cancer	1.04e-05	7.75e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APOA1—stomach cancer	1.03e-05	7.74e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6R—stomach cancer	1.03e-05	7.71e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.02e-05	7.64e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CD44—stomach cancer	1.02e-05	7.61e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—TYMS—stomach cancer	1.01e-05	7.58e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—MAPK1—stomach cancer	1.01e-05	7.57e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—EGFR—stomach cancer	1.01e-05	7.57e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PRKCB—stomach cancer	1.01e-05	7.52e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PRKCB—stomach cancer	1e-05	7.5e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTP1—stomach cancer	1e-05	7.49e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6ST—stomach cancer	1e-05	7.49e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTM1—stomach cancer	1e-05	7.49e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6ST—stomach cancer	9.98e-06	7.47e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—TYMS—stomach cancer	9.88e-06	7.39e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—HMOX1—stomach cancer	9.88e-06	7.39e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.87e-06	7.39e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	9.87e-06	7.38e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	9.83e-06	7.35e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTM1—stomach cancer	9.77e-06	7.31e-05	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—PIK3CA—stomach cancer	9.67e-06	7.23e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SERPINE1—stomach cancer	9.65e-06	7.22e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APC—stomach cancer	9.62e-06	7.2e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APC—stomach cancer	9.59e-06	7.17e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—KRAS—stomach cancer	9.56e-06	7.15e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PPARG—stomach cancer	9.49e-06	7.1e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTT1—stomach cancer	9.45e-06	7.07e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APC—stomach cancer	9.44e-06	7.06e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ERCC2—stomach cancer	9.41e-06	7.04e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2A6—stomach cancer	9.34e-06	6.99e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TYMS—stomach cancer	9.31e-06	6.97e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RHOA—stomach cancer	9.31e-06	6.97e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PPARG—stomach cancer	9.3e-06	6.96e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NOS3—stomach cancer	9.22e-06	6.9e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—MAPK3—stomach cancer	9.21e-06	6.89e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTM1—stomach cancer	9.21e-06	6.89e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ERCC2—stomach cancer	9.19e-06	6.87e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	9.19e-06	6.87e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AKR1C3—stomach cancer	9.09e-06	6.8e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	9.04e-06	6.76e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6R—stomach cancer	8.93e-06	6.68e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6R—stomach cancer	8.91e-06	6.66e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ENO1—stomach cancer	8.86e-06	6.62e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MTHFR—stomach cancer	8.85e-06	6.62e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PIK3CA—stomach cancer	8.78e-06	6.57e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—MAPK1—stomach cancer	8.77e-06	6.56e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6R—stomach cancer	8.77e-06	6.56e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—EGFR—stomach cancer	8.77e-06	6.56e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	8.74e-06	6.54e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—EGFR—stomach cancer	8.74e-06	6.54e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ERCC2—stomach cancer	8.66e-06	6.48e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPP2R1A—stomach cancer	8.65e-06	6.47e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MTHFR—stomach cancer	8.63e-06	6.46e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ERBB2—stomach cancer	8.62e-06	6.45e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	8.6e-06	6.44e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	8.6e-06	6.43e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALB—stomach cancer	8.54e-06	6.39e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTP1—stomach cancer	8.49e-06	6.35e-05	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	8.38e-06	6.27e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HMOX1—stomach cancer	8.37e-06	6.26e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SERPINE1—stomach cancer	8.37e-06	6.26e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALB—stomach cancer	8.36e-06	6.25e-05	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	8.35e-06	6.25e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	8.34e-06	6.24e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—KRAS—stomach cancer	8.28e-06	6.19e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—KRAS—stomach cancer	8.25e-06	6.18e-05	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	8.22e-06	6.15e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	8.21e-06	6.14e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL8—stomach cancer	8.18e-06	6.12e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—NOS3—stomach cancer	8.17e-06	6.11e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CAV1—stomach cancer	8.16e-06	6.1e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOA1—stomach cancer	8.14e-06	6.09e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MTHFR—stomach cancer	8.14e-06	6.09e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	8.13e-06	6.08e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—HRAS—stomach cancer	8.12e-06	6.08e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RHOA—stomach cancer	8.07e-06	6.04e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RHOA—stomach cancer	8.04e-06	6.02e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—NOS3—stomach cancer	8e-06	5.98e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NOS3—stomach cancer	7.99e-06	5.98e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	7.98e-06	5.97e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CAV1—stomach cancer	7.96e-06	5.96e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NOS3—stomach cancer	7.96e-06	5.96e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOA1—stomach cancer	7.95e-06	5.94e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RHOA—stomach cancer	7.92e-06	5.92e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TYMS—stomach cancer	7.89e-06	5.9e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CD44—stomach cancer	7.85e-06	5.88e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NOS3—stomach cancer	7.84e-06	5.86e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTM1—stomach cancer	7.8e-06	5.83e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.8e-06	5.83e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—stomach cancer	7.77e-06	5.82e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCND1—stomach cancer	7.62e-06	5.7e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	7.61e-06	5.69e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—JUN—stomach cancer	7.6e-06	5.69e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	7.58e-06	5.67e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CAV1—stomach cancer	7.51e-06	5.61e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOA1—stomach cancer	7.49e-06	5.6e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ERBB2—stomach cancer	7.47e-06	5.59e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—stomach cancer	7.47e-06	5.59e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	7.47e-06	5.58e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ERBB2—stomach cancer	7.45e-06	5.57e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MMP9—stomach cancer	7.4e-06	5.53e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	7.37e-06	5.51e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ERCC2—stomach cancer	7.33e-06	5.49e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	7.33e-06	5.48e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—stomach cancer	7.31e-06	5.47e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MAPK8—stomach cancer	7.19e-06	5.38e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPARG—stomach cancer	7.17e-06	5.37e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL8—stomach cancer	7.08e-06	5.3e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL8—stomach cancer	7.06e-06	5.28e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—HRAS—stomach cancer	7.04e-06	5.27e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—HRAS—stomach cancer	7.02e-06	5.25e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPARG—stomach cancer	7e-06	5.24e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	6.95e-06	5.2e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CDKN1B—stomach cancer	6.92e-06	5.18e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	6.91e-06	5.17e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	6.9e-06	5.16e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MTHFR—stomach cancer	6.89e-06	5.16e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	6.79e-06	5.08e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—stomach cancer	6.74e-06	5.04e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—stomach cancer	6.72e-06	5.02e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPP2R1A—stomach cancer	6.68e-06	5e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VEGFA—stomach cancer	6.64e-06	4.97e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—stomach cancer	6.61e-06	4.95e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCND1—stomach cancer	6.6e-06	4.94e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPARG—stomach cancer	6.6e-06	4.94e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—JUN—stomach cancer	6.59e-06	4.93e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCND1—stomach cancer	6.58e-06	4.92e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—STAT3—stomach cancer	6.58e-06	4.92e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—JUN—stomach cancer	6.57e-06	4.91e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTP1—stomach cancer	6.55e-06	4.9e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCND1—stomach cancer	6.48e-06	4.85e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—JUN—stomach cancer	6.46e-06	4.84e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HMOX1—stomach cancer	6.46e-06	4.83e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALB—stomach cancer	6.45e-06	4.83e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MMP9—stomach cancer	6.41e-06	4.79e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MMP9—stomach cancer	6.39e-06	4.78e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CDKN1A—stomach cancer	6.39e-06	4.78e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	6.36e-06	4.76e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CAV1—stomach cancer	6.36e-06	4.76e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOA1—stomach cancer	6.34e-06	4.75e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALB—stomach cancer	6.3e-06	4.71e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MMP9—stomach cancer	6.29e-06	4.7e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MAPK3—stomach cancer	6.28e-06	4.7e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	6.27e-06	4.69e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MAPK8—stomach cancer	6.23e-06	4.66e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MAPK8—stomach cancer	6.21e-06	4.65e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—NOS3—stomach cancer	6.17e-06	4.62e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	6.12e-06	4.57e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MYC—stomach cancer	6.11e-06	4.57e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TYMS—stomach cancer	6.09e-06	4.56e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.07e-06	4.54e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—NOS3—stomach cancer	6.02e-06	4.51e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTM1—stomach cancer	6.02e-06	4.5e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MAPK1—stomach cancer	5.98e-06	4.47e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—EGFR—stomach cancer	5.98e-06	4.47e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALB—stomach cancer	5.93e-06	4.44e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VEGFA—stomach cancer	5.75e-06	4.3e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VEGFA—stomach cancer	5.74e-06	4.29e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—STAT3—stomach cancer	5.7e-06	4.26e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—STAT3—stomach cancer	5.68e-06	4.25e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—NOS3—stomach cancer	5.68e-06	4.25e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ERCC2—stomach cancer	5.66e-06	4.23e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	5.65e-06	4.22e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—KRAS—stomach cancer	5.65e-06	4.22e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—stomach cancer	5.64e-06	4.22e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—STAT3—stomach cancer	5.59e-06	4.18e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPARG—stomach cancer	5.59e-06	4.18e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—stomach cancer	5.51e-06	4.12e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MAPK3—stomach cancer	5.44e-06	4.07e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MAPK3—stomach cancer	5.43e-06	4.06e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	5.34e-06	4e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MTHFR—stomach cancer	5.32e-06	3.98e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MYC—stomach cancer	5.29e-06	3.96e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MYC—stomach cancer	5.28e-06	3.95e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MYC—stomach cancer	5.2e-06	3.89e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—stomach cancer	5.19e-06	3.88e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	5.19e-06	3.88e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MAPK1—stomach cancer	5.18e-06	3.87e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—EGFR—stomach cancer	5.18e-06	3.87e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MAPK1—stomach cancer	5.16e-06	3.86e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—EGFR—stomach cancer	5.16e-06	3.86e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	5.08e-06	3.8e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—EGFR—stomach cancer	5.08e-06	3.8e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALB—stomach cancer	5.03e-06	3.76e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TP53—stomach cancer	5.02e-06	3.75e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CAV1—stomach cancer	4.91e-06	3.67e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOA1—stomach cancer	4.9e-06	3.66e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—KRAS—stomach cancer	4.89e-06	3.66e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—KRAS—stomach cancer	4.88e-06	3.65e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NOS3—stomach cancer	4.81e-06	3.6e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—KRAS—stomach cancer	4.8e-06	3.59e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HRAS—stomach cancer	4.8e-06	3.59e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PIK3CA—stomach cancer	4.59e-06	3.44e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—stomach cancer	4.59e-06	3.44e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PIK3CA—stomach cancer	4.5e-06	3.37e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PIK3CA—stomach cancer	4.49e-06	3.36e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	4.48e-06	3.35e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	4.41e-06	3.3e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—stomach cancer	4.4e-06	3.29e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TP53—stomach cancer	4.35e-06	3.25e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TP53—stomach cancer	4.33e-06	3.24e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPARG—stomach cancer	4.31e-06	3.23e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TP53—stomach cancer	4.27e-06	3.19e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HRAS—stomach cancer	4.16e-06	3.11e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HRAS—stomach cancer	4.14e-06	3.1e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HRAS—stomach cancer	4.08e-06	3.05e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—stomach cancer	3.98e-06	2.98e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—stomach cancer	3.97e-06	2.97e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—stomach cancer	3.91e-06	2.92e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALB—stomach cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NOS3—stomach cancer	3.71e-06	2.78e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3CA—stomach cancer	3.47e-06	2.6e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—stomach cancer	3.39e-06	2.54e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3CA—stomach cancer	3.39e-06	2.54e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3CA—stomach cancer	3.19e-06	2.39e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3CA—stomach cancer	2.71e-06	2.02e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.09e-06	1.56e-05	CbGpPWpGaD
